Inspiratory Muscle Training for Childhood Asthma
(iPro Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help children with obesity and asthma breathe easier and stay more active. It tests inspiratory muscle rehabilitation (IMR), which uses a special device that provides resistance while inhaling, similar to strength training for the lungs. The trial seeks children aged 8 to 17 who have mild asthma, are dealing with obesity, and are already using prescription asthma medication. Participants will use a device at home to determine if it can ease breathing and enhance activity levels. As an unphased trial, this study offers a unique opportunity for participants to contribute to innovative research that could improve their quality of life.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study is testing an add-on intervention, it is likely that you can continue your current asthma medications.
What prior data suggests that this inspiratory muscle training is safe for children with obesity and asthma?
Research has shown that inspiratory muscle training (IMT) is generally safe for children. Studies have found that IMT can improve lung function and strengthen breathing muscles without causing major side effects. One study showed that eight weeks of IMT strengthened breathing muscles in children with chest burns, indicating it is well-tolerated. Another study found that IMT reduced symptoms and improved the quality of life for children with asthma. These studies did not report any serious negative effects, suggesting that IMT is safe and well-tolerated in similar groups.12345
Why are researchers excited about this trial?
Researchers are excited about inspiratory muscle training (IMR) for childhood asthma because it offers a fresh approach to managing the condition. Unlike traditional treatments, which often rely on medications like inhaled corticosteroids and bronchodilators, IMR focuses on strengthening the respiratory muscles. The PrO2™ device used in this training provides a unique delivery method by offering real-time biofeedback and personalized resistance levels, enhancing the effectiveness of each session. This method not only aims to improve lung function but also empowers patients by involving them actively in their treatment process.
What evidence suggests that inspiratory muscle rehabilitation is effective for childhood asthma?
Research has shown that inspiratory muscle training (IMT) can strengthen breathing muscles and improve lung function in children with asthma. In this trial, participants in the active inspiratory muscle rehabilitation (IMR) group will use the PrO2™ device to reach a target resistance of 60% of their maximum inspiratory pressure (MIP). Studies have found that this training can increase vital capacity, the maximum air a person can exhale after a deep breath, and peak expiratory flow rate, the speed of exhaling air. Other research indicates that IMT also enhances exercise ability and reduces breathlessness. These benefits are particularly important for children with both asthma and obesity, as they often experience more severe breathing problems. Overall, IMT has shown promising results in making breathing easier and more efficient for young asthma patients.12678
Who Is on the Research Team?
Jason Lang, MD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for children aged 8-17 with obesity and mild asthma. They must be on asthma medication, speak/read English, have internet access and a supportive caregiver. Excluded are those with severe respiratory history, pregnancy plans, lung surgery within two years or conditions preventing safe participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo inspiratory muscle rehabilitation (IMR) using the PrO2™ device for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Inspiratory Pulmonary Rehabilitation
Inspiratory Pulmonary Rehabilitation is already approved in United States, European Union for the following indications:
- Obesity-related asthma in children
- Chronic obstructive pulmonary disease (COPD)
- Asthma
- Pulmonary hypertension (PH)
- Interstitial lung disease (ILD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
American Lung Association
Collaborator